PharmaCyte Biotech Inc.

NASDAQ: PMCB · Real-Time Price · USD
1.02
0.01 (0.99%)
At close: Aug 19, 2025, 1:54 PM

PharmaCyte Biotech Cash Flow Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Apr 30, 2025 Apr 30, 2024 Apr 30, 2023 Apr 30, 2022 Apr 30, 2021
Net Income
30.66M 333.76K -4.32M -4.24M -3.55M
Depreciation & Amortization
n/a n/a n/a n/a n/a
Stock-Based Compensation
478.64K 674.69 645.41K 77.96K 370.83K
Other Working Capital
1.35M 37.8K -54.22K -24.06K -132.03K
Other Non-Cash Items
-35.47M -2.78M 174.02K 34.85K -4.87K
Deferred Income Tax
n/a n/a n/a n/a n/a
Change in Working Capital
1.36M 298.89K -297.17K 9.04K -145.61K
Operating Cash Flow
-2.98M -2.15M -3.79M -4.12M -3.33M
Capital Expenditures
-4 -3 n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a
Purchase of Investments
-7M -5M n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a
Investing Cash Flow
-7M -5M n/a n/a n/a
Debt Repayment
n/a n/a n/a -50.8 -62.44
Common Stock Repurchased
-25.03M -44.36M -13.56M n/a n/a
Dividend Paid
-1.13M n/a n/a n/a n/a
Other Financial Acitivies
1.13M n/a 880.00 -50.75K -62.38K
Financial Cash Flow
-25.03M -10.71M -13.56M 87.31M 4.64M
Net Cash Flow
-35.01M -17.86M -17.36M 83.2M 1.31M
Free Cash Flow
-2.98M -2.15M -3.79M -4.12M -3.33M